Hyaluronic-Coated Albumin Nanoparticles for the Non-Invasive Delivery of Apatinib in Diabetic Retinopathy

References

• Bhagat N, Zarbin MA. Epidemiology, risk factors, and pathophysiology of diabetic retinopathy. In: Bandello F, editor. Clinical Strategies in the Management of Diabetic Retinopathy: A Step-By-Step Guide for Ophthalmologists. Cham: Springer International Publishing; 2019:1–19.
   Google Scholar
• Lakhani P, Patil A, Majumdar S. Recent advances in topical nano drug-delivery systems for the anterior ocular segment. Ther Deliv. 2018;9(2):137–153. doi:10.4155/tde-2017-0088
   PubMed Web of Science ®Google Scholar
• Cabrera FJ, Wang DC, Reddy K, Acharya G, Shin CS. Challenges and opportunities for drug delivery to the posterior of the eye. Drug Discov Today. 2019;24(8):1679–1684. doi:10.1016/j.drudis.2019.05.035
   PubMed Web of Science ®Google Scholar
• Suri R, Beg S, Kohli K. Target strategies for drug delivery bypassing ocular barriers. J Drug Deliv Sci Tech. 2020;55.
   Google Scholar
• Laradji AM, Kolesnikov AV, Karakocak BB, Kefalov VJ, Ravi N. Redox-responsive hyaluronic acid-based nanogels for the topical delivery of the visual chromophore to retinal photoreceptors. ACS Omega. 2021;6(9):6172–6184. doi:10.1021/acsomega.0c05535
   PubMedGoogle Scholar
• Yadav D, Varma LT, Yadav K, et al. Drug delivery to posterior segment of the eye: conventional delivery strategies, their barriers, and restrictions. In: Patel JK, editor. Drug Delivery for the Retina and Posterior Segment Disease. Cham: Springer International Publishing; 2018:51–67.
   Google Scholar
• Omerović N, Vranić E. Application of nanoparticles in ocular drug delivery systems. Health Technol (Berl). 2020;10(1):61–78. doi:10.1007/s12553-019-00381-w
   Web of Science ®Google Scholar
• Karimi M, Bahrami S, Ravari SB, et al. Albumin nanostructures as advanced drug delivery systems. Expert Opin Drug Deliv. 2016;13(11):1609–1623. doi:10.1080/17425247.2016.1193149
   PubMed Web of Science ®Google Scholar
• Verma D, Gulati N, Kaul S, Mukherjee S, Nagaich U. Protein based nanostructures for drug delivery. J Pharm (Cairo). 2018;2018:9285854. doi:10.1155/2018/9285854
   PubMed Web of Science ®Google Scholar
• Tao C, Chuah YJ, Xu C, Wang D-A. Albumin conjugates and assemblies as versatile bio-functional additives and carriers for biomedical applications. J Mater Chem B. 2019;7(3):357–367. doi:10.1039/C8TB02477D
   PubMedGoogle Scholar
• Tan YL, Ho HK. Navigating albumin-based nanoparticles through various drug delivery routes. Drug Discov Today. 2018;23(5):1108–1114. doi:10.1016/j.drudis.2018.01.051
   PubMed Web of Science ®Google Scholar
• Kim D, Maharjan P, Jin M, et al. Potential albumin-based antioxidant nanoformulations for ocular protection against oxidative stress. Pharmaceutics. 2019;11(7):297. doi:10.3390/pharmaceutics11070297
   PubMed Web of Science ®Google Scholar
• Noomwong P, Ratanasak W, Polnok A, Sarisuta N. Development of acyclovir-loaded bovine serum albumin nanoparticles for ocular drug delivery. Int J Drug Deliv. 2011;3:669–675.
   Google Scholar
• Das S, Bellare JR, Banerjee R. Protein based nanoparticles as platforms for aspirin delivery for ophthalmologic applications. Colloids Surf B Biointerfaces. 2012;93:161–168. doi:10.1016/j.colsurfb.2011.12.033
   PubMed Web of Science ®Google Scholar
• Minatelli JA, Stephen Hill W, Moerck RE. Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin. 09795631;15193236. 2017.
   Google Scholar
• Naik JB, Pardeshi SR, Patil RP, Patil PB, Mujumdar A. Mucoadhesive micro-/nano carriers in ophthalmic drug delivery: an overview. BioNanoScience. 2020;10(3):564–582. doi:10.1007/s12668-020-00752-y
   Web of Science ®Google Scholar
• Martens TF, Remaut K, Deschout H, et al. Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy. J Control Release. 2015;202:83–92. doi:10.1016/j.jconrel.2015.01.030
   PubMed Web of Science ®Google Scholar
• Huang D, Chen YS, Rupenthal ID. Hyaluronic acid coated albumin nanoparticles for targeted peptide delivery to the retina. Mol Pharm. 2017;14(2):533–545. doi:10.1021/acs.molpharmaceut.6b01029
   PubMed Web of Science ®Google Scholar
• Huang D, Chen YS, Thakur SS, Rupenthal ID. Ultrasound-mediated nanoparticle delivery across ex vivo bovine retina after intravitreal injection. Eur J Pharm Biopharm. 2017;119:125–136. doi:10.1016/j.ejpb.2017.06.009
   PubMed Web of Science ®Google Scholar
• Huerta Angeles G, Nesporova K. Hyaluronan and its derivatives for ophthalmology: recent advances and future perspectives. Carbohydr Polym. 2021;259:117697. doi:10.1016/j.carbpol.2021.117697
   PubMedGoogle Scholar
• Halasz K, Kelly SJ, Iqbal MT, Pathak Y, Sutariya V. Utilization of apatinib-loaded nanoparticles for the treatment of ocular neovascularization. Curr Drug Deliv. 2019;16(2):153–163. doi:10.2174/1567201815666181017095708
   PubMedGoogle Scholar
• Lee JE, Kim KL, Kim D, et al. Apatinib-loaded nanoparticles suppress vascular endothelial growth factor-induced angiogenesis and experimental corneal neovascularization. Int J Nanomedicine. 2017;12:4813–4822. doi:10.2147/IJN.S135133
   PubMed Web of Science ®Google Scholar
• Kim KL, Suh W. Apatinib, an inhibitor of vascular endothelial growth factor receptor 2, suppresses pathologic ocular neovascularization in mice. Invest Ophthalmol Vis Sci. 2017;58(9):3592–3599. doi:10.1167/iovs.17-21416
   PubMedGoogle Scholar
• Jeong JH, Nguyen HK, Lee JE, Suh W. Therapeutic effect of apatinib-loaded nanoparticles on diabetes-induced retinal vascular leakage. Int J Nanomedicine. 2016;11:3101–3109. doi:10.2147/IJN.S108452
   PubMed Web of Science ®Google Scholar
• Storp B, Engel A, Boeker A, Ploeger M, Langer K. Albumin nanoparticles with predictable size by desolvation procedure. J Microencapsul. 2012;29(2):138–146. doi:10.3109/02652048.2011.635218
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang Q. Establishment of CTAB turbidimetric method to determine hyaluronic acid content in fermentation broth. Carbohydr Polym. 2009;78(1):178–181. doi:10.1016/j.carbpol.2009.04.037
   Web of Science ®Google Scholar
• Yu Z, Yu M, Zhang Z, Hong G, Xiong Q. Bovine serum albumin nanoparticles as controlled release carrier for local drug delivery to the inner ear. Nanoscale Res Lett. 2014;9(1):343. doi:10.1186/1556-276X-9-343
   PubMedGoogle Scholar
• Graca A, Goncalves LM, Raposo S, Ribeiro HM, Marto J. Useful in vitro techniques to evaluate the mucoadhesive properties of hyaluronic acid-based ocular delivery systems. Pharmaceutics. 2018;10(3):110. doi:10.3390/pharmaceutics10030110
   PubMed Web of Science ®Google Scholar
• Lai AK, Lo AC. Animal models of diabetic retinopathy: summary and comparison. J Diabetes Res. 2013;2013:106594. doi:10.1155/2013/106594
   PubMed Web of Science ®Google Scholar
• Rahimnejad M, Najafpour G, Bakeri G. Investigation and modeling effective parameters influencing the size of BSA protein nanoparticles as colloidal carrier. Colloids Surf a Physicochem Eng Asp. 2012;412:96–100. doi:10.1016/j.colsurfa.2012.07.022
   Google Scholar
• Galisteo-Gonzalez F, Molina-Bolivar JA. Systematic study on the preparation of BSA nanoparticles. Colloids Surf B Biointerfaces. 2014;123:286–292. doi:10.1016/j.colsurfb.2014.09.028
   PubMed Web of Science ®Google Scholar
• Tarhini M, Benlyamani I, Hamdani S, et al. Protein-based nanoparticle preparation via nanoprecipitation method. Materials (Basel). 2018;11(3):394. doi:10.3390/ma11030394
   PubMed Web of Science ®Google Scholar
• Jahanban-Esfahlan A, Dastmalchi S, Davaran S. A simple improved desolvation method for the rapid preparation of albumin nanoparticles. Int J Biol Macromol. 2016;91:703–709. doi:10.1016/j.ijbiomac.2016.05.032
   PubMed Web of Science ®Google Scholar
• Wu Y, Yao J, Zhou J, Dahmani FZ. Enhanced and sustained topical ocular delivery of cyclosporine A in thermosensitive hyaluronic acid-based in situ forming microgels. Int J Nanomedicine. 2013;8:3587–3601. doi:10.2147/IJN.S47665
   PubMed Web of Science ®Google Scholar
• Apaolaza PS, Busch M, Asin-Prieto E, et al. Hyaluronic acid coating of gold nanoparticles for intraocular drug delivery: evaluation of the surface properties and effect on their distribution. Exp Eye Res. 2020;198:108151. doi:10.1016/j.exer.2020.108151
   PubMed Web of Science ®Google Scholar
• Hu D, Mezghrani O, Zhang L, et al. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy. Int J Nanomedicine. 2016;11:5125–5147. doi:10.2147/IJN.S113469
   PubMed Web of Science ®Google Scholar
• Bronze-Uhle ES, Costa BC, Ximenes VF, Lisboa-Filho PN. Synthetic nanoparticles of bovine serum albumin with entrapped salicylic acid. Nanotechnol Sci Appl. 2017;10:11–21. doi:10.2147/NSA.S117018
   PubMed Web of Science ®Google Scholar
• Hyung W, Ko H, Park J, et al. Novel hyaluronic acid (HA) coated drug carriers (HCDCs) for human breast cancer treatment. Biotechnol Bioeng. 2008;99(2):442–454. doi:10.1002/bit.21578
   PubMed Web of Science ®Google Scholar
• Lee S, Lee CD, Ahn JB, et al. Hyaluronic acid-coated solid lipid nanoparticles to overcome drug-resistance in tumor cells. J Drug Deliv Sci Technol. 2019;50:365–371. doi:10.1016/j.jddst.2019.01.042
   Web of Science ®Google Scholar
• Silva B, Marto J, Braz BS, et al. New nanoparticles for topical ocular delivery of erythropoietin. Int J Pharm. 2020;576:119020. doi:10.1016/j.ijpharm.2020.119020
   PubMed Web of Science ®Google Scholar
• Aguilera-Garrido A, Molina-Bolívar JA, Gálvez-Ruiz MJ, Galisteo-González F. Mucoadhesive properties of liquid lipid nanocapsules enhanced by hyaluronic acid. J Mol Liq. 2019;296:111965. doi:10.1016/j.molliq.2019.111965
   Web of Science ®Google Scholar
• Zeng W, Li Q, Wan T, et al. Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability. Colloids Surf B Biointerfaces. 2016;141:28–35. doi:10.1016/j.colsurfb.2016.01.014
   PubMed Web of Science ®Google Scholar
• Horváthy DB, Simon M, Schwarz CM, et al. Serum albumin as a local therapeutic agent in cell therapy and tissue engineering. Biofactors. 2017;43(3):315–330. doi:10.1002/biof.1337
   PubMed Web of Science ®Google Scholar
• Merodio M, Irache JM, Valamanesh F, Mirshahi M. Ocular disposition and tolerance of ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats. Biomaterials. 2002;23(7):1587–1594. doi:10.1016/s0142-9612(01)00284-8
   PubMedGoogle Scholar
• Shi Y, Liu Y, Zheng Y, et al. Ethanol extract of chinese propolis attenuates early diabetic retinopathy by protecting the blood–retinal barrier in streptozotocin‐induced diabetic rats. J Food Sci. 2019;84(2):358–369. doi:10.1111/1750-3841.14435
   PubMedGoogle Scholar
• Kniggendorf VF, Novais EA, Kniggendorf SL, et al. Effect of intravitreal anti-VEGF on choroidal thickness in patients with diabetic macular edema using spectral domain OCT. Arq Bras Oftalmol. 2016;79(3):155–158. doi:10.5935/0004-2749.20160047
   PubMedGoogle Scholar
• Gawish M, Mazen N, Hassen E, Adbelhady M. Light and electron microscopic study on the possible ameliorative role of adipose-derived mesenchymal stem cells on diabetic retinopathy in adult male albino rats. Egypt J Histol. 2018;41(4):582–596. doi:10.21608/ejh.2018.4129.1011
   Google Scholar
• Roy S, Maiello M, Lorenzi M. Increased expression of basement membrane collagen in human diabetic retinopathy. J Clin Invest. 1994;93(1):438–442. doi:10.1172/JCI116979
   PubMedGoogle Scholar
• Mrugacz M, Bryl A, Zorena K. Retinal vascular endothelial cell dysfunction and neuroretinal degeneration in diabetic patients. J Clin Med. 2021;10(3):458. doi:10.3390/jcm10030458
   PubMedGoogle Scholar
• Kalam MA. The potential application of hyaluronic acid coated chitosan nanoparticles in ocular delivery of dexamethasone. Int J Biol Macromol. 2016;89:559–568. doi:10.1016/j.ijbiomac.2016.05.016
   PubMed Web of Science ®Google Scholar
• Kyyrönen K, Hume L, Benedetti L, et al. Methylprednisolone esters of hyaluronic acid in ophthalmic drug delivery: in vitro and in vivo release studies. Int J Pharm. 1992;80(1–3):161–169. doi:10.1016/0378-5173(92)90274-6
   Google Scholar
• Kalam MA. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone. Int J Biol Macromol. 2016;89:127–136. doi:10.1016/j.ijbiomac.2016.04.070
   PubMed Web of Science ®Google Scholar
• Mochimaru H, Takahashi E, Tsukamoto N, et al. Involvement of hyaluronan and its receptor CD44 with choroidal neovascularization. Invest Ophthalmol Vis Sci. 2009;50(9):4410–4415. doi:10.1167/iovs.08-3044
   PubMedGoogle Scholar
• Chandola C, Casteleijn MG, Chandola UM, et al. CD44 aptamer mediated cargo delivery to lysosomes of retinal pigment epithelial cells to prevent age-related macular degeneration. Biochem Biophys Rep. 2019;18:100642. doi:10.1016/j.bbrep.2019.100642
   PubMedGoogle Scholar
• Mains J, Wilson CG. The vitreous humor as a barrier to nanoparticle distribution. J Ocul Pharmacol Ther. 2013;29(2):143–150. doi:10.1089/jop.2012.0138
   PubMed Web of Science ®Google Scholar
• Lieleg O, Ribbeck K. Biological hydrogels as selective diffusion barriers. Trends Cell Biol. 2011;21(9):543–551. doi:10.1016/j.tcb.2011.06.002
   PubMed Web of Science ®Google Scholar
• Peng Y, Yu Y, Lin L, et al. Glycosaminoglycans from bovine eye vitreous humour and interaction with collagen type II. Glycoconj J. 2018;35(1):119–128. doi:10.1007/s10719-017-9808-1
   PubMed Web of Science ®Google Scholar
• Kim H, Robinson SB, Csaky KG. Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina. Pharm Res. 2009;26(2):329–337. doi:10.1007/s11095-008-9745-6
   PubMedGoogle Scholar
• Huang D, Chen YS, Green CR, Rupenthal ID. Hyaluronic acid coated albumin nanoparticles for targeted peptide delivery in the treatment of retinal ischaemia. Biomaterials. 2018;168:10–23. doi:10.1016/j.biomaterials.2018.03.034
   PubMed Web of Science ®Google Scholar
• Homme RP, Singh M, Majumder A, et al. Remodeling of retinal architecture in diabetic retinopathy: disruption of ocular physiology and visual functions by inflammatory gene products and pyroptosis. Front Physiol. 2018;9:1268. doi:10.3389/fphys.2018.01268
   PubMed Web of Science ®Google Scholar
• Bennett TJ. Available from: https://www.opsweb.org/page/FAinterpretation?&hhsearchterms=%22angiogram%22. Accessed June 18, 2021.
   Google Scholar